| [1] |
赵建国，廖泉，赵玉沛. 胰腺癌分子标志物研究进展［J/CD］. 中华普外科手术学杂志（电子版），2013，7（03）：224-226.
|
| [2] |
Salmena L，Poliseno L，Tay Y，et al. A ceRNA Hypothesis：The Rosetta Stone of a Hidden RNA Language？［J］. Cell，2011，146（3）：353-358.
|
| [3] |
Tay Y，Rinn J，Pandolfi P P. The multilayered complexity of ceRNA crosstalk and competition［J］. Nature，2014，505（7483）：344-352.
|
| [4] |
Necsulea A，Soumillon M，Warnefors M，et al. The evolution of lncRNA repertoires and expression patterns in tetrapods［J］. Nature，2014，505（7485）：635-640.
|
| [5] |
Zhang H D，Jiang L H，Sun D W，et al. CircRNA：a novel type of biomarker for cancer［J］. Breast Cancer，2018，25（1）：1-7.
|
| [6] |
Lou W，Ding B，Fu P. Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer［J］. Front Cell Dev Biol，2020，8：85.
|
| [7] |
Liu P，Pan Y，Wang D，et al. Long non-coding RNA XIST promotes cell proliferation of pancreatic cancer through miR-137 and Notch1 pathway［J］. Eur Rev Med Pharmacol Sci，2020，24（23）：12161-12170.
|
| [8] |
Han Q，Li J，Xiong J，et al. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression［J］. J Exp Clin Cancer Res，2020，39（1）：151.
|
| [9] |
Guo Z，Wang X，Yang Y，et al. Hypoxic Tumor-Derived Exosomal Long Noncoding RNA UCA1 Promotes Angiogenesis via miR-96-5p/AMOTL2 in Pancreatic Cancer［J］. Molecular Therapy - Nucleic Acids，2020，22：179-195.
|
| [10] |
Xiong G，Liu C，Yang G，et al. Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer［J］. Journal of Hematology & Oncology，2019，12（1）：97.
|
| [11] |
Lei S，He Z，Chen T，et al. Long noncoding RNA 00976 promotes pancreatic cancer progression through OTUD7B by sponging miR-137 involving EGFR/MAPK pathway［J］. J Exp Clin Cancer Res，2019，38（1）：470.
|
| [12] |
Liu Y，Wang J，Dong L，et al. Long Noncoding RNA HCP5 Regulates Pancreatic Cancer Gemcitabine（GEM）Resistance By Sponging Hsa-miR-214-3p To Target HDGF［J］. Onco Targets Ther，2019，12：8207-8216.
|
| [13] |
Sun Y，Wang P，Yang W，et al. The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis［J］. Cancer Biology & Therapy，2019，20（6）：729-739.
|
| [14] |
Hua Y，Zhu Y，Xie G，et al. Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine resistance in pancreatic cancer via upregulating TWF1［J］. Aging（Albany NY），2019，11（20）：8860-8878.
|
| [15] |
Ling S，He Y，Li X，et al. CircRHOT1 mediated cell proliferation，apoptosis and invasion of pancreatic cancer cells by sponging miR‐125a‐3p［J］. Journal of cellular and molecular medicine，2020，24（17）：9881-9889.
|
| [16] |
Han X，Fang Y，Chen P，et al. Upregulated circRNA hsa_circ_0071036 promotes tumourigenesis of pancreatic cancer by sponging miR-489 and predicts unfavorable characteristics and prognosis［J］. Cell Cycle，2021，20（4）：369-382.
|
| [17] |
Wong CH，Lou UK，Li Y，et al. CircFOXK2 Promotes Growth and Metastasis of Pancreatic Ductal Adenocarcinoma by Complexing with RNA-Binding Proteins and Sponging MiR-942［J］. Cancer Res，2020，80（11）：2138-2149.
|
| [18] |
Shen P，Yang T，Chen Q，et al. CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing［J］. Mol Cancer，2021，20（1）：51.
|
| [19] |
Kong Y，Li Y，Luo Y，et al. circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer［J］. Mol Cancer，2020，19（1）：82.
|
| [20] |
Han X，Fang Y，Chen P，et al. Upregulated circRNA hsa_circ_0071036 promotes tumourigenesis of pancreatic cancer by sponging miR-489 and predicts unfavorable characteristics and prognosis［J］. Cell Cycle，2021，20（4）：369-382.
|
| [21] |
Yu S，Wang M，Zhang H，et al. Circ_0092367 Inhibits EMT and Gemcitabine Resistance in Pancreatic Cancer via Regulating the miR-1206/ESRP1 Axis［J］. Genes（Basel），2021，12（11）：1701.
|
| [22] |
Ma HW，Xie M，Sun M，et al. The pseudogene derived long noncoding RNA DUXAP8 promotes gastric cancer cell proliferation and migration via epigenetically silencing PLEKHO1 expression［J］. Oncotarget，2017，8（32）：52211-52224.
|
| [23] |
Huang W，Li N，Hu J，et al. Inhibitory effect of RNA-mediated knockdown of zinc finger protein 91 pseudogene on pancreatic cancer cell growth and invasion［J］. Oncol Lett，2016，12（2）：1343-1348.
|
| [24] |
Lian Y，Yang J，Lian Y，et al. DUXAP8，a pseudogene derived lncRNA，promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2［J］. Cancer Commun（Lond），2018，38（1）：64.
|
| [25] |
Abue M，Yokoyama M，Shibuya R，et al. Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer［J］. Int J Oncol，2015，46（2）：539-547.
|
| [26] |
Cao R，Wang K，Long M，et al. miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6［J］. Cell Cycle，2020，19（22）：3086-3095.
|
| [27] |
Xu B，Liu J，Xiang X，et al. Expression of miRNA-143 in Pancreatic Cancer and Its Clinical Significance［J］. Cancer Biother Radiopharm，2018，33（9）：373-379.
|
| [28] |
Yu Y，Tong Y，Zhong A，et al. Identification of Serum microRNA-25 as a novel biomarker for pancreatic cancer［J］. Medicine（Baltimore），2020，99（52）：e23863.
|
| [29] |
Guz M，Jeleniewicz W，Cybulski M，et al. Serum miR-210-3p can be used to differentiate between patients with pancreatic ductal adenocarcinoma and chronic pancreatitis［J］. Biomed Rep，2021，14（1）：10.
|
| [30] |
Meng Q，Liang C，Hua J，et al. A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance：functional validation and clinical significance［J］. Theranostics，2020，10（9）：3967-3979.
|
| [31] |
Zibitt M M S，Hartford CCR，Lal A. Interrogating lncRNA functions via CRISPR/Cas systems［J］. RNA Biol，2021，18（12）：2097-2106.
|